These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25637807)

  • 21. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.
    Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S
    Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
    J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
    J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
    Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
    Jyoti A; Plano A; Riedel G; Platt B
    J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease.
    Roh JH; Jiang H; Finn MB; Stewart FR; Mahan TE; Cirrito JR; Heda A; Snider BJ; Li M; Yanagisawa M; de Lecea L; Holtzman DM
    J Exp Med; 2014 Dec; 211(13):2487-96. PubMed ID: 25422493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease.
    Girard SD; Jacquet M; Baranger K; Migliorati M; Escoffier G; Bernard A; Khrestchatisky M; Féron F; Rivera S; Roman FS; Marchetti E
    Hippocampus; 2014 Jul; 24(7):762-72. PubMed ID: 24596271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits.
    Van Erum J; Van Dam D; Sheorajpanday R; De Deyn PP
    Behav Brain Res; 2019 Nov; 373():112089. PubMed ID: 31325518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.
    Snir JA; Suchy M; Lawrence KS; Hudson RH; Pasternak SH; Bartha R
    J Alzheimers Dis; 2015; 48(1):73-87. PubMed ID: 26401930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
    Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
    Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease.
    Kaczorowski CC; Sametsky E; Shah S; Vassar R; Disterhoft JF
    Neurobiol Aging; 2011 Aug; 32(8):1452-65. PubMed ID: 19833411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.
    Kimura R; Ohno M
    Neurobiol Dis; 2009 Feb; 33(2):229-35. PubMed ID: 19026746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
    Brandscheid C; Schuck F; Reinhardt S; Schäfer KH; Pietrzik CU; Grimm M; Hartmann T; Schwiertz A; Endres K
    J Alzheimers Dis; 2017; 56(2):775-788. PubMed ID: 28035935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of methylphenidate on the behavior of male 5xFAD mice.
    Schneider F; Baldauf K; Wetzel W; Reymann KG
    Pharmacol Biochem Behav; 2015 Jan; 128():68-77. PubMed ID: 25449360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
    Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
    J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.